Details of the Drug

General Information of Drug (ID: DMG9WJO)

Drug Name

IMF-001

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01234012) Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1. U.S. National Institutes of Health.